Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0400-2024Class II

BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533

Becton Dickinson Infusion Therapy Systems Inc. / initiated 2023-10-04 / Open, Classified / root cause: manufacturing process

Becton Dickinson Infusion Therapy Systems Inc. began a recall of BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533 on . FDA classified it as Class II and gives the reason as "Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0400-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Becton Dickinson Infusion Therapy Systems Inc.
Product
BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533
Product code
FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days
Reason for recall
Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 10/4/23, recall notices were emailed to customers and distributors who were asked to do the following: 1) Destroy all unused product subject to the recall following your institution's process for destruction. 2) For indwelling catheters, no further action is needed. 3) Share this recall notification with all users within your facility network of the product to ensure they are also aware of this recall. 4) Complete and return the customer response form via email to [email protected] Customers with recall questions, product complaints, or technical questions can call 1-844-823-5433, say recall when prompted, Mon-Fri 8:00am to 5:00PM CT, or email [email protected] In addition, distributors are asked to identify all customers within their distribution network that purchased affected product. Then distributors should provide a copy of the customer letter to these customers and advise them of the recall.
Quantity in commerce
528,000
Distribution
US Nationwide distribution in the states of CA, NC, MI, WA, CO, FL, NJ, NM, IL, KY, TN, OH, TX, IN, LA, IA, MS, MO, NE, MD, NY, PA, GA, VA, ME, SC, RI, MA, PR.
Product codes and lots
UDI-DI: 00382903825332, Lot: 3166524, Expiration: 2026/05/31

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0400-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0400-2024Class IIOngoingVoluntary: Firm initiated